The Effect of Qingrehuayuziyin Prescription on Lymphocyte Apoptosis and Expression of Fas and Bcl-2 in Peripheral Blood in the Patients with Systemic Lupus Erythematosus

LIANG Wei; CAI Ying; ZHANG Li-ling; TANG Yong-ming; GONG Ling; JIN Lin; JIANG Ke-chun

您当前的位置：

首页 >

文章列表页 >

The Effect of Qingrehuayuziyin Prescription on Lymphocyte Apoptosis and Expression of Fas and Bcl-2 in Peripheral Blood in the Patients with Systemic Lupus Erythematosus

更新时间：2024-09-23

- The Effect of Qingrehuayuziyin Prescription on Lymphocyte Apoptosis and Expression of Fas and Bcl-2 in Peripheral Blood in the Patients with Systemic Lupus Erythematosus
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 16, Issue 2, Pages: 116-119(2010)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2010
- 稿件说明：
移动端阅览
LIANG Wei, CAI Ying, ZHANG Li-ling, et al. The Effect of Qingrehuayuziyin Prescription on Lymphocyte Apoptosis and Expression of Fas and Bcl-2 in Peripheral Blood in the Patients with Systemic Lupus Erythematosus[J]. Chinese journal of experimental traditional medical formulae, 2010, 16(2): 116-119.
DOI：

LIANG Wei, CAI Ying, ZHANG Li-ling, et al. The Effect of Qingrehuayuziyin Prescription on Lymphocyte Apoptosis and Expression of Fas and Bcl-2 in Peripheral Blood in the Patients with Systemic Lupus Erythematosus[J]. Chinese journal of experimental traditional medical formulae, 2010, 16(2): 116-119. DOI：

摘要

目的 :探讨中药清热化瘀滋阴方对系统性红斑狼疮(SLE)患者外周血淋巴细胞凋亡及相关基因(Fas

Bcl-2)表达的影响。方法 :临床筛选SLE患者80例

完全随机分为治疗组(清热化瘀滋阴方配合激素组)和对照组(单用激素组)各40例

服药3个月

淋巴细胞分离液分离治疗前后SLE患者外周血淋巴细胞

采用流式细胞仪检测淋巴细胞凋亡率;采用Rt-PCR法检测淋巴细胞Fas

Bcl-2基因表达情况。结果 :清热化瘀滋阴方治疗后SLE患者外周血淋巴细胞凋亡率较治疗前明显下降(P<0.01)

并明显低于对照组(P<0.01);两组治疗后Fas

Bcl-2基因的表达均明显下降

治疗组Fas基因的表达明显低于对照组(P<0.01)。结论 :清热化瘀滋阴方可能通过降低SLE患者外周血淋巴细胞凋亡率

下调淋巴细胞Fas

Bcl-2基因的表达水平

改善免疫紊乱而发挥作用。

Abstract

Objective: To investigate the effect of Qingrehuayuziyin prescription on lymphocyte apoptosis and expression of Fas and Bcl-2 in peripheral blood in the patients with systemic lupus erythematosus (SLE). Methods : Eighty patients with SLE were selected and divided randomly into two groups

40 in the therapy group and 40 in control group respectively. Patients were got the treatment of Qingrehuayuziyin prescription combined hormone as therapy group and got hormone treating only as control group. After treating three months

the patients lymphocyte were collected and the rate of apoptosis were detected by flow cytometer. Meanwhile

the expression of Fas and Bcl-2 were analyzed by RT-PCR. Results: After 3 months treating

the rate of lymphocyte apoptosis was decreased significantly in therapy group compared with that in control group and with that in pre-treating(P<0.01). The expression of Fas and Bcl-2

compared with that in control group

were also decreased significantly (P<0.01). Conclusion : Qingrehuayuziyin prescription is useful for treating SLE by suppressing lymphocyte apoptosis

decreasing the level of Fas and Bcl-2 in peripheral blood and further modifying the immune status.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

The Effect of Qingrehuayuziyin Prescription on Lymphocyte Apoptosis and Expression of Fas and Bcl-2 in Peripheral Blood in the Patients with Systemic Lupus Erythematosus

Treatment of Sepsis-induced Inflammatory Responses with Xijiao Dihuangtang by Modulation of PKM2-mediated One-carbon Metabolism Pathway

Mitochondrial Quality Control Regulating Pathogenesis of Sarcopenia and Its Intervention by Traditional Chinese Medicine： A Review

Mechanism of Modified Danggui Shaoyaosan in Improving Inflammation and Apoptosis in Acne via Regulating JNK/p38 MAPK Pathway

Programmed Cell Death in Endometriosis and Traditional Chinese Medicine Intervention： A Review

Related Author

LIANG Wei

CAI Ying

ZHANG Li-ling

TANG Yong-ming

GONG Ling

JIN Lin

JIANG Ke-chun

YAN Qixiang

Related Institution

Department of Traditional Medicine,No.454 Hospital of PLA

Affiliated Hospital of Nanjing University of Chinese Medicine

The First Clinical Medical College，Nanjing University of Chinese Medicine

Jiangsu Province Hospital of Chinese Medicine

The First Affiliated Hospital of Henan University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰